Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
about
"Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary diseaseCirculating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer researchProgress in circulating tumor cell capture and analysis: implications for cancer managementImaging circulating tumor cells in freely moving awake small animals using a miniaturized intravital microscopeRecent advances in the biology of human circulating tumour cells and metastasisPotential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current EvidenceThe Challenges of Detecting Circulating Tumor Cells in SarcomaEMT, CTCs and CSCs in tumor relapse and drug-resistanceHuman breast cancer metastases to the brain display GABAergic properties in the neural niche.Mesenchymal phenotype of CTC-enriched blood fraction and lymph node metastasis formation potential.Circulating Tumor Cells in Early-Stage Breast Cancer.Circulating tumor cells in breast cancer.Analysis of circulating tumor cells in breast cancer.Circulating tumor cells: from bench to bedsideSerial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients.CTC enumeration and characterization: moving toward personalized medicine.Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination.A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer.May CTC technologies promote better cancer management?Circulating tumor cells in newly diagnosed inflammatory breast cancer.Inhibition of established micrometastases by targeted drug delivery via cell surface-associated GRP78.Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker.Classification of circulating tumor cells by epithelial-mesenchymal transition markersThe impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients.Circulating Tumor Cells Detected by RT-PCR for CK-20 before Surgery Indicate Worse Prognostic Impact in Triple-Negative and HER2 Subtype Breast Cancer.Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristicsEpithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.Progress in using circulating tumor cell information to improve metastatic breast cancer therapyEstablishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients.Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survivalClinical challenges in the molecular characterization of circulating tumour cells in breast cancer.A negative selection methodology using a microfluidic platform for the isolation and enumeration of circulating tumor cellsHeterogeneity of mesenchymal markers expression-molecular profiles of cancer cells disseminated by lymphatic and hematogenous routes in breast cancer.Interplay of Stem Cell Characteristics, EMT, and Microtentacles in Circulating Breast Tumor Cells.Breast Cancer Biomarkers: Utility in Clinical Practice.Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes.A circulating tumor cell cluster-based model for tumor metastasis (Hypothesis).Clinical implications of the detection of circulating tumor cells in breast cancer patients.Enrichment, detection and clinical significance of circulating tumor cells.Circulating tumour cells--a bona fide cause of metastatic cancer.
P2860
Q21131903-ACC0D087-7148-40EC-B623-9E4B4A2B3E3FQ27024191-DDABF5F9-52F0-43A3-A395-28D5B47110F4Q27025737-F1ADADDB-0539-408B-98D3-30F206420673Q27329640-F8773A91-0F17-40F7-A5AE-6976C6BBA269Q28070120-F45D8F4C-B202-410F-9EE8-165ECB1EE112Q28075850-60F5234B-61CF-4220-B723-6BC51FCF0108Q28078659-8AD881CF-26BA-4FC8-A51D-8201C0434663Q28082935-D33B7C1D-2101-4158-AA79-C84D5186705AQ30569512-11202A69-D21C-418E-BBE7-C05ACE53133EQ31158116-DAA8959D-F25D-4D38-ABBB-40B312AE5B00Q33579111-133BAB41-456B-4AED-8780-52FCE9BC3ECCQ34077349-EA10291C-08D8-4898-B0DA-59CD5DA88A47Q34156275-5AF72B78-E0DE-4A78-B3BF-39D5BBAC5CC1Q34307782-2FDA44E5-44C2-43C0-8B8D-D5FC71325759Q34485182-896441CE-B709-4035-B77C-3523F1E1B03DQ34577724-50DEF426-7556-41A2-99A3-A8F18E7646D7Q35000278-F0E2EA1B-B97D-4849-A928-3327004F2BEAQ35001280-73B45193-EA93-4559-BBDC-77931580D8C5Q35016353-CF0C083B-5504-4648-8B0D-90DE47FE7C87Q35052773-35E7CD74-7922-4610-8864-09F479EAD6D0Q35090829-39C194EE-E0C3-4A19-BD89-97F2EC14AE7AQ35519793-7A5E106A-1187-472A-9EFE-A4426A117356Q35536715-D853420F-4DA0-4E76-B151-37856735D99CQ35619770-E5DB2AD4-85DA-4C2A-A9AB-2980E647C5CEQ35866927-AE9AFA23-0730-4B87-AC77-B476F517E41FQ36097761-5032F04A-15A8-4216-8C9F-6FB669D877EBQ36406697-BF805F56-E705-4C01-8F6D-BE6727FF7D11Q36752761-B586D03A-4AD8-4036-9483-B8F1DE4D8033Q36869787-A07CA8D3-229C-4F9E-9490-6B229DB9A279Q36924468-3CB47C66-13F4-4B73-B3FB-6E6CB9F312D0Q36959162-F69A127E-A293-4333-BD11-59C4E451A690Q37382776-E3A3838F-2EFA-4190-AD89-08374FF2027FQ37420594-BB2A6A0D-9235-4512-8049-3F74DCD96F07Q37420601-44F2540E-F1CF-4065-B9BA-E078BC3F3ADCQ37441159-A64BDC6C-60BE-4786-A413-8AB2F166712CQ37507435-36C23D8E-B502-46B3-A5E4-59ED7DA34EEAQ37582197-6C693A64-81F2-48F6-8BEC-2F771B52EE64Q37980500-5B89CBA4-98FC-431E-80FA-99623567839CQ38102590-FCC322CA-4759-4D32-95F2-25E193A2561FQ38210937-83C5D1B2-E83A-4833-B004-5C3BAE10B0EF
P2860
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Circulating tumor cells as pro ...... first-line systemic treatment
@ast
Circulating tumor cells as pro ...... first-line systemic treatment
@en
type
label
Circulating tumor cells as pro ...... first-line systemic treatment
@ast
Circulating tumor cells as pro ...... first-line systemic treatment
@en
prefLabel
Circulating tumor cells as pro ...... first-line systemic treatment
@ast
Circulating tumor cells as pro ...... first-line systemic treatment
@en
P2093
P2860
P356
P1476
Circulating tumor cells as pro ...... first-line systemic treatment
@en
P2093
Beverly C Handy
Gabriel N Hortobagyi
James M Reuben
Kenneth R Hess
Mario Giuliano
Massimo Cristofanilli
Michal Mego
Naoto T Ueno
Ricardo H Alvarez
Sabino De Placido
P2860
P2888
P356
10.1186/BCR2907
P577
2011-06-15T00:00:00Z
P5875
P6179
1013357138